| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |